Connect with us
This alliance focuses on said patent for the preparation of a preclinical antibody program against the IL-18 binding protein. Under the terms of the agreement, Compugen...
Acceleron Pharma's CMO resigns despite company claims of a strong outlook for a cancer wonder drug.
Keytruda, a cancer drug developed by Merck & Co, was able to notably shrink the tumors of 48 out of 88 patients. Another 18 saw their...